Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CPA1 | P15085 | 7/20 | 0.58 |
| ▸ | CPA3 | P15088 | 3/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.58 |
| ▸ | CPB1 | P15086 | 1/20 | 0.58 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7267044 | 1.00 | SLC1A1 (0.67) | SLC1A1CYP1A2CPA1CPA3FOLH1 | |
| SCHEMBL27816147 | 1.00 | SLC1A1 (0.67) | SLC1A1CYP1A2CPA1CPA3FOLH1 | |
| SCHEMBL8839263 | 0.91 | SLC1A1 (0.73) | SLC1A1CYP1A2CPA1CPA3FOLH1 | |
| SCHEMBL28294483 | 0.86 | SLC1A1 (0.67) | SLC1A1CYP1A2CPA1CPA3FOLH1 | |
| SCHEMBL8701198 | 0.84 | SLC1A1 (0.57) | SLC1A1CYP1A2CPA1CPA3FOLH1 | |
| SCHEMBL16000772 | 0.84 | SLC1A1 (0.65) | SLC1A1CYP1A2CPA3FOLH1CA1 | |
| SCHEMBL13103435 | 0.83 | SLC1A1 (0.52) | SLC1A1CYP1A2CA1CA2CA7 | |
| SCHEMBL16898388 | 0.83 | SLC1A1 (0.63) | SLC1A1CYP1A2CPA3FOLH1CA1 | |
| SCHEMBL16898390 | 0.83 | SLC1A1 (0.63) | SLC1A1CYP1A2CPA3FOLH1CA1 | |
| SCHEMBL17884784 | 0.81 | SLC1A1 (0.61) | SLC1A1CYP1A2CPA1CPA3FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102127005-B | Intermediate of alvimopan and synthesis method thereof | BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD | 2012-11-21 | — | — | CN | claimed |
| CN-102127005-A | Intermediate of alvimopan and synthesis method thereof | BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD | 2011-07-20 | — | — | CN | claimed |
| CN-102127005-B | Intermediate of alvimopan and synthesis method thereof | BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD | 2012-11-21 | — | — | CN | disclosed |
| CN-102127005-A | Intermediate of alvimopan and synthesis method thereof | BRIGHTGENE BIO MEDICAL TECHNOLOGY CO LTD | 2011-07-20 | — | — | CN | disclosed |